Mark your calendars: May 8th first patient should be done receiving CDNF. And if you don't think results will start slipping out to all the need to know analysts crawling across biotech, think again.
If CDNF and this delivery system are safe and show results, we can uplist on that alone, we will receive funding on that alone. Nothing else matters. If we are on the field through 2018, and that trial shows some success, we are go for launch.